Activists sound alarm bells as Gilead seeks rights over HIV drug

Lenacapavir, a very expensive drug, is not available in India and many other countries. If the Indian Patent Office clears Gilead's patent applications, generic drug makers in India will not be allowed to produce its affordable forms.